A 48-week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus (Q42983656)
Jump to navigation
Jump to search
scientific article published on 27 February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 48-week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus |
scientific article published on 27 February 2004 |
Statements
1 reference
A 48-week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus (English)
1 reference
G L Drusano
1 reference
S L Preston
1 reference
27 February 2004
1 reference
1 reference
189
1 reference
6
1 reference
964-970
1 reference
Identifiers
1 reference
1 reference